• OPEN AN ACCOUNT
Indian Indices
Nifty
25,795.15 -96.25
(-0.37%)
Sensex
84,778.84 566.96
( 0.67%)
Bank Nifty
57,699.60 -378.45
( -0.65%)
Nifty IT
35,986.35 -92.30
( -0.26%)
Global Indices
Nasdaq
47,235.40 479.79
(1.03%)
Dow Jones
6,814.07 54.63
(0.81%)
Hang Seng
50,457.07 1,157.42
(2.35%)
Nikkei 225
9,645.62 67.05
(0.70%)
Forex
USD-INR
87.83 0.08
(0.09%)
EUR-INR
101.91 0.09
(0.09%)
GBP-INR
117.11 -0.04
(-0.03%)
JPY-INR
0.58 0.00
(-0.39%)

EQUITY - MARKET SCREENER

Divis Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
532488
INE361B01024
561.0868795
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DIVISLAB
74.86
174885.39
EPS(TTM)
Face Value()
Div & Yield %
88
2
0.45
 

JSW Energy Ltd - Board Meeting Outcome for Outcome Of The Board Meeting Held On 17Th October 2025
Oct 17,2025
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) we hereby inform you that the Board of Directors at its meeting held today has inter-alia approved the unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30th September 2025. A copy of the said Financial Results containing disclosures required under Regulations 33 52 54 and other provisions of the Listing Regulations as applicable together with the Limited Review Reports by Deloitte Haskins & Sells LLP. Chartered Accountants and security cover certificate under Regulation 54(3) and 56(1)(d) of the Listing Regulations is enclosed. A press release issued by the Company is also attached. The Board Meeting commenced at 4:00 p.m. and concluded at 5.45 p.m.